The GLP-1 RA with the highest number of reports was semaglutide, accounting for 655 cases (38.33%)
Tirzepatide is a medication that targets two hormones involved in appetite regulation and metabolic function: GLP-1 GIP Together, these hormones help: reduce appetite, slow digestion, improve fullness, stabilize blood sugar, reduce cravings, and naturally lower calorie intake
This medicine belongs to the meglitinide class, a group of insulin secretagogues that stimulate the pancreas to release insulin
The primary physiological role of L-Carnitine involves facilitating the transport of long-chain fatty acids across the inner mitochondrial membrane via the carnitine palmitoyltransferase (CPT) enzyme system
GLP-1 medications were originally developed to treat type 2 diabetes and remain highly effective at improving blood sugar control
Clinical aspects of Down syndrome from infancy to adulthood